Australia's Proteomics hits near two-week low on discounted placement

Proteomics International Laboratories

15/08/2022 05:06

** Shares of Proteomics International Laboratories Ltd
 PIQ.AX  drop as much as 4.1% to A$0.94 after trading resumes
following a two-day halt, hits their lowest level since Aug 3
    ** Medical tech company announces capital raise of A$8 mln
($5.68 mln) to fund PromakerD Test used for diabetic kidney
disease in the U.S.  urn:newsml:reuters.com:*:nASXbDv6zJ
    ** Issues 9.41 million shares at A$0.85/share, a discount of
13.3% to the stock's close on Aug 10
    ** More than 220,000 shares change hands, compared with the
30-day average volume of about 88,000 shares
    ** Stock down 19.3% this year, as of last close
 


($1 = 1.4094 Australian dollars)

 (Reporting by John Biju in Bengaluru)
 ((john.biju@thomsonreuters.com))